First of all, you dont need to decide for yourself
The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial
The dispersion between Novo and Lilly again goes to show the incredible power of competition to dictate stock outcomes: despite Novos excellent financial performance since 2023 (31% growth in 2023, 25% growth in 2024, 48% EBIT margins), the stock has declined because of competition: investors think Eli Lilly is the emerging winner within GLP-1s, given the stronger weight loss profile of tirzepatide (Mounjaro/Zepbound) versus semaglutide (Ozempic/Wegovy), and Lillys more attractive weight loss pipeline assets
doi:10.1007/bf01316798
When sourcing retatrutide for pharmaceutical development, work with manufacturers who provide comprehensive documentation packages including Certificates of Analysis, stability study reports, residual solvent analysis, heavy metal screening results, and endotoxin testing data
Weighed down by stigma: How weight-based social identity threat contributes to weight gain and poor health
